Bristol-Myers Agrees to Acquire Inhibitex (BMY, INHX)
Bristol-Myers Squibb Co. (NYSE: BMY), the New York City-based biotechnology company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis, today announced that it entered...